Led enterprise strategy, special projects, & competitive intelligence for the global DNA sequencing leader (~$5B annual revenue)• Led annual strategic planning process - including articulating 5 yr. vision, strategic imperatives, & investment / M&A priorities• Accountable for enterprise strategy, but with special focus on product roadmap, China, oncology diagnostics, & new business models • Established and led the competitive intelligence function; responsible for market sensing, war-gaming, and adjusting corporate strategy to mitigate rapidly intensifying competitive threats• Oversaw multiple company-wide optimization programs resulting in $200M+ in annul recurring financial impact (i.e., revenue / earnings maximization efforts involving large portfolios of cross-functional initiatives)• Author of ILMN’s highest profile internal & external strategy documents – including quarterly board presentations & investor presentations (e.g., JP Morgan healthcare conference, Illumina Investor Day) • Strategy lead on multiple $100M+ M&A and PE transactions related to ILMN’s expansions in multi-omics & clinical diagnostics

Strategy & transformation leader for the #1 ranked global healthcare consultancy (by revenue); Focused on commercial and digital strategy for Fortune 500 & Mid-Cap life sciences clients• Strategy & Business development leader with $15M+ annual sales• Established Deloitte's Mid-Cap Life Sciences practice and grew its revenue to $250M+/yr. • Specialized in commercial strategy, innovative operating models, capability-building, scenario planning, and product launch • Head of community-building for Deloitte’s largest Consulting office with over 2000 practitionersHighlights from Client work: • Commercial Models: Designed & implemented a transformational commercial model for a mid-sized specialty pharma ($2B revenue) including vision, strategy, and implementation playbooks • Launch Readiness: Defined cross-functional plans for multiple biopharma launching first products – covering all key activities in the ~24 month lead up to launch• Digital Health: Developed a mobile phone-based patient engagement program for a leading diabetes franchise; demonstrated effective behavior change across 4 trial sites and 300+ patients • Patient Engagement & Support: Led the overhaul of patient support services at a top 10 pharma; including transformation of call center operations, payer navigation, adherence, & specialty pharmacy • Sales Force Effectiveness: Leveraged data science methods (e.g., k-means clustering) to segment and prioritize physician targets & tailor messaging for #1 therapeutics in both immuno-oncology & PCSK9 • Digital Transformation: Architected a 4-year program to build out comprehensive digital commercial capabilities for a global med tech leader; secured ~$75M funding to build it• Due Diligence: Prevented a non-accretive $250M acquisition based on primary research & modeling commercial potential • Supply Chain: Developed a manufacturing and sourcing strategy to quadruple the global supply of a high-profile pandemic flu treatment

• Conducted deal screening and investment due diligence for mezzanine debt financing deals in the middle-market• Analyzed portfolio risk and performed competitor benchmarking to inform investment decisions• Assisted in leveraged / management buyouts, recaps, acquisitions, and growth capital transactions

• Led projects to improve cancer infusion center throughput, operating room infection control, & patient placement processes• Collaborated with hospital staff to drive impactful changes & implement solutions for operational efficiency and patient care